Prostate Cancer VL

Clinical Conversation: CHAARTED, LATITUDE and STAMPEDE

Details
(Length of discussion ~ 27 minutes) Charles Ryan hosts a discussion with Alicia Morgans and Christopher Sweeney regarding data from the LATITUDE, STAMPEDE and CHAARTED trials, and the survivor endpoints for patients receiving initial androgen deprivation therapy (ADT) for metastatic prostate cancer. Specifically, discussed is the interface of these three very important studies and the many treatme...

Over-treatment in the Name of Cure: Revisiting Adjuvant Therapy in the Modern Era? - Christopher Sweeney

Details
(Length of discussion - 26 minutes) Christopher Sweeney, MD presents on the Over-treatment in the Name of Cure: Revisiting Adjuvant Therapy in the Modern Era? Dr. Sweeney addresses how we can cure more men from prostate cancer by taking a look at preventing relapse after definitive local therapy and radiation and hormonal therapy together vs radiation therapy alone. He reflects on the length of ti...

Is the Evidence Sufficient to Recommend Statins for All Men With Prostate Cancer?- Lorelei Mucci

Details
(Length of lecture ~ 19 minutes) Alicia Morgans hosts a discussion with Lorelei Mucci on her recently-published article in the Journal of Clinical Oncology that reviews a study on the association between statin use and the mortality rate in Danish patients who have prostate cancer. This study leverages the unique data sets available in Scandinavian countries where nationwide health registers can b...

18F-Fluciclovine: A New Option for Biochemical Recurrence in Prostate Cancer - Trond V. Bogsrud

Details
(Length of lecture ~ 15 minutes) Trond V. Bogsrud, MD presented "18F-Fluciclovine: A New Option for Biochemical Recurrence in Prostate Cancer” at the SNMMI 2016, detailing the uptake of fluciclovine (18F) as a PET imaging radiotracer in comparison to other PET tracers in patients with biochemically recurrent prostate cancer. Additional content on 18F - Fluciclovine Stepping Into the Light: "Radiol...

Prostate Cancer and Molecular Tracers: 11C/18F-Choline for Biochemical Recurrence - Laura Evangelista

Details
(Length of lecture ~ 17 minutes) Laura Evangelista, MD PhD presented " Prostate Cancer and Molecular Tracers: 11C/18F-Choline for Biochemical Recurrence” at the SNMMI 2016, Dr. Evangelista details the best radiopharmaceutical agent: 11C/18F-Choline and the clinical role and ability to affect patient management and survival of prostate cancer. Additional content on Prostate Cancer and Molecular Tra...

Plasma Based Biomarkers in Advanced Prostate Cancer - Gerhardt Attard

Details
(Length of Presentation: 16 min) Gerhardt Attard, MD focuses on DNA Plasma-based biomarkers in advanced prostate cancer during his 2017 APCCC presentation on the rationale for using plasma DNA. Plasma collection is routine and are adding to the registries allows for ongoing clinical trials. Circulating tumor DNA is detected in plasma from all progressing mCRPC patients. Plasma DNA is representativ...

APCCC 2017: Interview With Dr. Iain Frame

Details
Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage

Using Biomarkers to Determine When Biopsy and When to Repeat the Biopsy- Stephen Williams

Details
In this slide presentation, Stephen Williams details using biomarkers to determine when to biopsy and when to repeat a prostate biopsy specifically: PSA, PHI, 4K, PCA3 and Confirm MDx. He overviews the patient journey pre and post biopsy and the process of determining which patients need a rebiopsy. Biography: Stephen B. Williams, MD Assistant Professor in Urology, Tenure-Track, Robert Earl Cone P...

Definitive Cryotherapy for Localized Prostate Cancer - J Stephen Jones

Details
Biography: J. Stephen Jones, MD, began his role as President of Cleveland Clinic Regional Hospitals and Family Health Centers in December 2014. When he took that role, there were nine regional hospitals and 18 family health centers. Two years later, Dr. Jones oversees 11 hospitals and more than 20 family health centers. Dr. Jones has published more than 200 articles in all major urological journal...

Adverse Effects of Androgen Deprivation Therapy - Matthew R. Smith

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer